Embedded Files
Name: Lisa Wilkins Email: lisa.wilkins2@nhs.net
Date published: June 2025
Date to review: September 2025
This paper provides some information for General Practices in South Yorkshire on the implementation of the NICE technology appraisal TA1026 for the use of tirzepatide for overweight and obesity.
This document should be read in conjunction with the SY tirzepatide position statement. Tirzepatide_SYICB__Position_Statement_May_2025_V2.pdf
Page updated
Report abuse